The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Drug metabolism in drug discovery and development
Open accessAbstract
Drug metabolism as a discipline plays an important role in drug discovery and development and the effects of drug metabolism on pharmacokinetics (PK), pharmacodynamics (PD), and safety should be carefully considered. This communication provides an overview of common strategies in the area of drug metabolism for improving PK/PD and safety profiles of drug candidates; these include, but are not limited to, collaboration with medicinal chemists on structure-activity relationships (SAR) to overcome high clearance, using deuterium replacement to further optimize a lead, prodrug approaches to circumvent formulation and delivery difficulties, and addressing issues such as species differences in metabolism, drug-drug interactions (DDI) and formation of reactive metabolites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Innovation in the pharmaceutical industry: New estimates of R&D costs
DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016) · Journal of Health Economics · doi:10.1016/j.jhealeco.2016.01.012 · Cited by 3,359
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
Gotoh, O. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48462-1 · Cited by 1,194
Evans, D. C., Watt, A. P., Nicoll-Griffith, D. A., & Baillie, T. A. (2004) · Chemical Research in Toxicology · doi:10.1021/tx034170b · Cited by 706
Tetrabenazine as antichorea therapy in Huntington disease: A randomized controlled trial
Huntington Study Group (2006) · Neurology · doi:10.1212/01.wnl.0000198586.85250.13 · Cited by 471
Structure of cytochrome P450eryF involved in erythromycin biosynthesis
Cupp-Vickery, J. R., & Poulos, T. L. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb0295-144 · Cited by 371
Preclinical experimental models of drug metabolism and disposition in drug discovery and development
Zhang, D., Luo, G., Ding, X., & Lu, C. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.10.004 · Cited by 309
Tetrabenazine as antichorea therapy in Huntington disease: A randomized controlled trial
Savani, A. A., & Login, I. S. (2007) · Neurology · doi:10.1212/01.wnl.0000259143.52138.5c · Cited by 299
Overview of enzymes of drug metabolism
Meyer, U. A. (1996) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf02353473 · Cited by 279
The Organic Chemistry of Drug Design and Drug Action
(2014) · Elsevier eBooks · doi:10.1016/c2009-0-64537-2 · Cited by 205
Gan, J., Harper, T. W., Hsueh, M.-M., Qu, Q., & Humphreys, W. G. (2005) · Chemical Research in Toxicology · doi:10.1021/tx0496791 · Cited by 178
Protein Adduct Formation as a Molecular Mechanism in Neurotoxicity
LoPachin, R. M., & DeCaprio, A. P. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi197 · Cited by 174
Compound lipophilicity for substrate binding to human P450s in drug metabolism
Lewis, D. F. V., Jacobs, M. N., & Dickins, M. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03115-0 · Cited by 172
Gallant, J. E., & Deresinski, S. (2003) · Clinical Infectious Diseases · doi:10.1086/378068 · Cited by 162
Otton, S. V., Crewe, H. K., Lennard, M. S., Tucker, G. T., & Woods, H. F. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20010-6 · Cited by 162
Venkatakrishnan, K., Greenblatt, D. J., Moltke, L. L., et al. (1998) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1998.tb04399.x · Cited by 155
Trunzer, M., Faller, B., & Zimmerlin, A. G. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8008663 · Cited by 125
Designing Drugs to Avoid Toxicity
Smith, G. F. (2011) · Progress in medicinal chemistry · doi:10.1016/b978-0-12-381290-2.00001-x · Cited by 123
Chapman, T. M., McGavin, J. K., & Noble, S. (2003) · Drugs · doi:10.2165/00003495-200363150-00006 · Cited by 103
Harada, N., Miwa, G. T., Walsh, J. S. A., & Lu, A. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43249-2 · Cited by 79
Liu, L., Halladay, J. S., Shin, Y. G., Wong, S., Coraggio, M., La, H., Baumgardner, M., Le, H. T., Gopaul, S., Boggs, J. W., et al. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040840 · Cited by 74
Zhang, Z., Chen, Q., Li, Y., Doss, G. A., Dean, B. J., Ngui, J. S., Elipe, M. V. S., Kim, S., Wu, J. Y., DiNinno, F. P., et al. (2005) · Chemical Research in Toxicology · doi:10.1021/tx0496789 · Cited by 59
Self-citationMetabolite Identification and Profiling in Drug Design: Current Practice and Future Directions
Zhang, Z., Zhu, M., & Tang, W. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788682460 · Cited by 59
Self-citationWenthur, C. J., Morrison, R. D., Felts, A. S., Smith, K. A., Engers, J. L., Byers, F. W., Daniels, J. S., Emmitte, K. A., Conn, P. J., & Lindsley, C. W. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400439t · Cited by 57
Ulrich, S., & L??uter, J. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241110-00004 · Cited by 54
Tatsumi, R., Fujio, M., Satoh, H., Katayama, J., Takanashi, S.-I., Hashimoto, K., & Tanaka, H. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049188d · Cited by 54
A quantitative high-throughput trapping assay as a measurement of potential for bioactivation
Meneses‐Lorente, G., Sakatis, M. Z., Schulz-Utermoehl, T., Nardi, C. D., & Watt, A. P. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.01.016 · Cited by 51
Inoue, K., Shibata, Y., Takahashi, H., Ohe, T., Chiba, M., & Ishii, Y. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.245 · Cited by 40
Lead Discovery and Lead Modification
Silverman, R. B., & Holladay, M. W. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-382030-3.00002-7 · Cited by 17
Bioactivation and Reactive Metabolite Assays
Tang, W., & Zhang, Z. (2012) · Wiley eBooks · doi:10.1002/9780470921920.edm113 · Cited by 2
Self-citation
Cited by
Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design
Vora, L. K., Gholap, A. D., Jetha, K., Thakur, R. R. S., Solanki, H. K., & Chavda, V. P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071916 · Cited by 1,061
Sultana, A., Zare, M., Thomas, V., Kumar, T. S. S., & Ramakrishna, S. (2022) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2022.100134 · Cited by 315
Flavonoids: A treasure house of prospective pharmacological potentials
Hasnat, H., Shompa, S. A., Islam, M. M., Alam, S., Richi, F. T., Emon, N. U., Ashrafi, S., Ahmed, N. U., Chowdhury, M. N. R., Fatema, N., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27533 · Cited by 263
Taking phototherapeutics from concept to clinical launch
Vickerman, B. M., Zywot, E. M., Tarrant, T. K., & Lawrence, D. S. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00326-w · Cited by 201
Application of In Vitro Metabolism Activation in High-Throughput Screening
Ooka, M., Lynch, C., & Xia, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218182 · Cited by 49
Metadata
- Authors
- Zhang, Z., & Tang, W.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 8
- Issue
- 5
- Pages
- 721-732
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W2799656331
- Cited by
- 360
- References
- 30
- FWCI
- 26.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.